Texas Ventures Acquisition IV Corp 8-K

What Happened
Texas Ventures Acquisition IV Corp announced the closing of its initial public offering on June 22, 2026. The IPO sold 17,250,000 units at $10.00 per unit (including a 2,250,000‑unit over‑allotment exercise) for gross proceeds of $172,500,000. Each unit includes one Class A ordinary share and one‑half of a redeemable warrant (one full warrant buys one share at $11.50). Simultaneously the company completed a private sale of 6,100,000 warrants at $1.00 each (total $6,100,000) to the Sponsor and Cohen & Company Capital Markets. The company entered into underwriting, warrant, trust and related agreements in connection with the offering and filed amended organizational documents with the Cayman Islands registrar.

Key Details

• IPO closed June 22, 2026: 17,250,000 units at $10.00 each; gross proceeds $172,500,000.
• Private placement: 6,100,000 warrants sold at $1.00 each ($6,100,000 total); Sponsor bought 3,775,000; Cohen & Company Capital Markets bought 2,325,000.
• Trust deposit: $173,362,500 of proceeds (which may include up to $6,900,000 deferred underwriter discount) was deposited in a U.S. trust account managed by Continental Stock Transfer & Trust Company. Interest may be released only to pay taxes and wind‑up expenses.
• Board and governance: On June 17, 2026 the company appointed R. Greg Smith, Andrew Clark, Harvin Moore and Aruna Viswanathan to the board (joining E. Scott Crist); Mr. Moore chairs the Audit and Compensation Committees. Indemnity agreements were entered with directors and officers.

Why It Matters
This filing confirms the SPAC successfully completed its offering and has placed most proceeds in a trust account, which is standard for blank‑check companies and protects investor funds until a business combination is completed. The trust funds will generally only be released on completion of an initial business combination or returned to public shareholders if the SPAC cannot complete a deal within the stated 18‑month period (or earlier liquidation date approved by the board). The private placement warrants held by the Sponsor and the underwriter establish sponsor economics and potential future dilution if those warrants are exercised. Investors should note the board composition, indemnity protections for officers/directors, and that the deposited proceeds could be subject to creditor claims under certain circumstances.